Page last updated: 2024-08-25

rosiglitazone and Thyroid Cancer, Anaplastic

rosiglitazone has been researched along with Thyroid Cancer, Anaplastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Antonelli, A; Basolo, F; Di Domenicantonio, A; Fallahi, P; Ferrannini, E; Ferrari, SM; Galleri, D; Miccoli, P; Piaggi, S; Santarpia, L	1

Other Studies

1 other study(ies) available for rosiglitazone and Thyroid Cancer, Anaplastic

Article	Year
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer. Cytokine, 2012, Volume: 59, Issue:2 Topics: Apoptosis; Cell Proliferation; Cell Survival; Chemokine CXCL10; Cytokines; Electrophoretic Mobility Shift Assay; Humans; Immunoblotting; Rosiglitazone; Th1 Cells; Thiazolidinediones; Thyroid Carcinoma, Anaplastic; Thyroid Gland; Thyroid Neoplasms	2012

Article

Year

Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer.

Cytokine, 2012, Volume: 59, Issue:2

Topics: Apoptosis; Cell Proliferation; Cell Survival; Chemokine CXCL10; Cytokines; Electrophoretic Mobility Shift Assay; Humans; Immunoblotting; Rosiglitazone; Th1 Cells; Thiazolidinediones; Thyroid Carcinoma, Anaplastic; Thyroid Gland; Thyroid Neoplasms

2012